> top > docs > PMC:7205724 > spans > 18897-19183 > annotations

PMC:7205724 / 18897-19183 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
652 136-144 Species denotes patients Tax:9606
656 78-96 Chemical denotes methylprednisolone MESH:D008775

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T142 5-19 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871
T143 109-123 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T165 78-96 Chemical denotes methylprednisolone http://purl.obolibrary.org/obo/CHEBI_6888

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T17 5-19 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes immunoglobulin http://purl.bioontology.org/ontology/MEDDRA/10021496
T18 109-123 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes immunoglobulin http://purl.bioontology.org/ontology/MEDDRA/10021496

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T81 248-255 http://purl.obolibrary.org/obo/OGMS_0000031 denotes disease

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T106 78-96 Chemical denotes methylprednisolone http://purl.obolibrary.org/obo/CHEBI_6888

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T151 30-209 Sentence denotes After switching to the double dose of 1600 mg/d methylprednisolone plus 20 g/d immunoglobulin, all of the patients improved in the clinical, laboratory, and paraclinical outcomes.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
656 78-96 Chemical denotes methylprednisolone MESH:D008775
652 136-144 Species denotes patients Tax:9606

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T6426 0-4 CC denotes plus
T60445 5-19 NN denotes immunoglobulin
T91733 20-21 -LRB- denotes (
T10263 21-27 CD denotes 10 g/d
T89099 27-28 -RRB- denotes )
T32422 30-35 IN denotes After
T38661 36-45 VBG denotes switching
T47400 46-48 TO denotes to
T27854 49-52 DT denotes the
T88178 53-59 JJ denotes double
T22917 60-64 NN denotes dose
T27562 65-67 IN denotes of
T69861 68-77 NN denotes 1600 mg/d
T26688 78-96 NN denotes methylprednisolone
T91618 97-101 CC denotes plus
T63033 102-108 NN denotes 20 g/d
T82872 109-123 NN denotes immunoglobulin
T48110 123-124 -COMMA- denotes ,
T64285 125-128 DT denotes all
T67888 129-131 IN denotes of
T16788 132-135 DT denotes the
T67776 136-144 NNS denotes patients
T6163 145-153 VBN denotes improved
T27596 154-156 IN denotes in
T10929 157-160 DT denotes the
T87507 161-169 JJ denotes clinical
T10805 169-170 -COMMA- denotes ,
T49266 171-181 NN denotes laboratory
T95692 181-182 -COMMA- denotes ,
T51590 183-186 CC denotes and
T63732 187-199 JJ denotes paraclinical
T58895 200-208 NNS denotes outcomes
T85504 210-217 JJ denotes Passive
T86520 218-230 NN denotes immunization
T22143 231-239 VBZ denotes protects
T80547 240-247 IN denotes against
T21735 248-255 NN denotes disease
T15590 255-256 -COMMA- denotes ,
T4169 257-260 CC denotes and
T50400 261-263 IN denotes so
T4187 264-266 PRP denotes it
T38504 267-273 MD denotes should
T8453 274-276 VB denotes be
R79540 T60445 T6426 arg2Of immunoglobulin,plus
R41260 T60445 T91733 arg1Of immunoglobulin,(
R75502 T10263 T91733 arg2Of 10 g/d,(
R50386 T89099 T91733 arg3Of ),(
R26413 T6163 T32422 arg1Of improved,After
R62745 T38661 T32422 arg2Of switching,After
R35046 T64285 T38661 arg1Of all,switching
R97543 T38661 T47400 arg1Of switching,to
R45642 T22917 T47400 arg2Of dose,to
R79576 T22917 T27854 arg1Of dose,the
R56085 T22917 T88178 arg1Of dose,double
R64025 T22917 T27562 arg1Of dose,of
R36622 T91618 T27562 arg2Of plus,of
R47040 T26688 T69861 arg1Of methylprednisolone,1600 mg/d
R96957 T26688 T91618 arg1Of methylprednisolone,plus
R59825 T82872 T91618 arg2Of immunoglobulin,plus
R2563 T82872 T63033 arg1Of immunoglobulin,20 g/d
R17542 T6163 T48110 arg1Of improved,","
R33163 T64285 T67888 arg1Of all,of
R47106 T67776 T67888 arg2Of patients,of
R68832 T67776 T16788 arg1Of patients,the
R41521 T64285 T6163 arg1Of all,improved
R92060 T6163 T27596 arg1Of improved,in
R79224 T58895 T27596 arg2Of outcomes,in
R14909 T58895 T10929 arg1Of outcomes,the
R43963 T58895 T87507 arg1Of outcomes,clinical
R46705 T87507 T10805 arg1Of clinical,","
R31644 T49266 T10805 arg2Of laboratory,","
R53992 T58895 T49266 arg1Of outcomes,laboratory
R52803 T51590 T95692 arg1Of and,","
R16749 T10805 T51590 arg1Of ",",and
R63324 T63732 T51590 arg2Of paraclinical,and
R41915 T58895 T63732 arg1Of outcomes,paraclinical
R55232 T86520 T85504 arg1Of immunization,Passive
R10991 T86520 T22143 arg1Of immunization,protects
R69581 T22143 T80547 arg1Of protects,against
R58848 T21735 T80547 arg2Of disease,against
R89140 T4169 T15590 arg1Of and,","
R87834 T22143 T4169 arg1Of protects,and
R82498 T4187 T38504 arg1Of it,should
R14592 T4187 T8453 arg1Of it,be

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T142 5-19 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871
T143 109-123 Body_part denotes immunoglobulin http://purl.org/sig/ont/fma/fma62871

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T151 30-209 Sentence denotes After switching to the double dose of 1600 mg/d methylprednisolone plus 20 g/d immunoglobulin, all of the patients improved in the clinical, laboratory, and paraclinical outcomes.